BackSeelos Therapeutics Overview

Seelos Therapeutics Other Income Expense Net

Other Income/Expense Net for SEEL.

Quarterly Other Income/Expense

$4.85M
↑ 126.04% YoY

As of Jun 30, 2024

Annual Other Income/Expense (TTM)

$33.90M
↑ 236.12% YoY

Trailing 12 months ending Jun 30, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin